BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2021
View Archived Issues
MGTA-117 confers better survival in preclinical models of AML
Read More
NanoViricides reports animal safety data on broad-spectrum anti-coronavirus drug candidate NV-CoV-2
Read More
Careful with that BBB
Read More
Janssen initiates phase II portion of first-in-human trial of talquetamab
Read More
Enrollment ongoing in phase III study of LNP-023 in adults with PNH with residual anemia
Read More
mNb6-tri, a novel potent trivalent nanobody against SARS-CoV-2
Read More
Panbela provides updates regarding its development of SBP-101
Read More
Updates on clinical development of the Parkinson's disease candidate YTX-7739
Read More
Silverback Therapeutics patents TGFR-1 inhibitors
Read More
Korean investigators disclose tubulin polymerization inhibitors
Read More
Kinnate Biopharma synthesizes new CDK inhibitors
Read More
French researchers describe PD-1/PD-L1 interaction inhibitors
Read More
New bispecific antibodies presented by WuXi Biologics
Read More
Phase III trials of ziritaxestat in IPF discontinued
Read More
Celularity presents preliminary phase I data on CYNK-001 in patients with AML with MRD
Read More
FDA clears IND for phase I/II trial of PhageBank in prosthetic joint infections
Read More
New phase III study evaluates AZD-9833 with palbociclib in ER-positive HER2-negative breast cancer
Read More
Mesoblast reports phase III data on rexlemestrocel-L for chronic low back pain
Read More
Artios initiates phase I/IIa trial of ATR inhibitor ART-0380 in advanced or metastatic solid tumors
Read More
Preliminary first-in-human data for NEXI-001 shows promise for patients with relapsed AML
Read More
Early signs of Batten disease stabilization seen with gene therapy AT-GTX-502
Read More
IND cleared in U.S. for phase II study of izokibep in ankylosing spondylitis
Read More
Dependencies join mutations in precision medicine search
Read More